HIRA

약제 급여적정성 재평가 합리화 방안 연구

  • 25
  • 47
Metadata Downloads
Type
Research report
Author(s)
박실비아김수진박은자손경복송은솔
Issued Date
2023-03
Keyword
약제급여적정성재평가
Publisher
건강보험심사평가원
URI
https://repository.hira.or.kr/handle/2019.oak/3227
Table Of Contents
제1장 서론 ············································································· 1
1. 연구 배경 및 필요성 ··············································································· 3
2. 연구 목적 ······························································································ 4
3. 연구 내용 및 방법 ·················································································· 4

제2장 건강보험 급여 의약품의 사용 현황 분석 ············································································· 7
1. 최근 10년 등재 약제 제품 수 및 청구현황 분석 ······································ 9
2. 최근 10년 인구구조 변화에 따른 청구추세 분석 ······································ 22

제3장 약제 급여적정성 재평가 제도 분석 ············································································· 29
1. 약제 급여적정성 재평가 제도 고찰 ························································· 31
2. 약제 급여적정성 재평가 대상 성분 및 2007년 이후 최초 등재 성분
청구현황 분석 ······················································································ 57

제4장 외국의 약제 급여적정성 재평가 제도 운영 현황 ············································································· 78
1. 프랑스 ································································································· 80
2. 일본 ···································································································· 93
3. 호주 ·································································································· 109

제5장 이해관계자, 전문가 심층면접조사 ············································································· 116
1. 연구 개요 ·························································································· 118
2. 연구 방법 ·························································································· 118
3. 연구 결과 ·························································································· 123
4. 함의 ·································································································· 134

제6장 약제 급여적정성 재평가의 합리적 시행 방안 ············································································· 138
1. 약제 급여적정성 재평가의 시행 방향 ·················································· 140
2. 향후 약제 급여적정성 재평가 시행 방안 ··············································· 144
3. 약제 급여적정성 재평가의 합리적 운영 방안 ········································· 161
4. 약제 급여적정성 재평가의 사회적 영향 ················································· 163

◾ 참고 문헌 ····················································································· 166
Publisher
건강보험심사평가원
Location
KOR
Citation
박실비아. (2023-03). 약제 급여적정성 재평가 합리화 방안 연구.
Appears in Collections:
HIRA 연구 > 2. 위탁연구
Authorize & License
  • Authorize공개
Files in This Item:

열람하신 정보에 대해 만족하십니까?

Comment

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.